150 related articles for article (PubMed ID: 2337874)
21. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
[TBL] [Abstract][Full Text] [Related]
22. DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphoma.
Juneja SK; Cooper IA; Hodgson GS; Wolf MM; Ding JC; Ironside PN; Thomas RJ; Parkin JD
J Clin Pathol; 1986 Sep; 39(9):987-92. PubMed ID: 3760241
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of DNA ploidy in lymphomas of the thyroid.
Zirker TA; Baybick JH; Vincent JL; Smith GJ; Siegal GP
Head Neck Surg; 1988; 10(5):324-9. PubMed ID: 3220773
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material.
Young GA; Hedley DW; Rugg CA; Iland HJ
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1497-504. PubMed ID: 3678313
[TBL] [Abstract][Full Text] [Related]
26. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease.
Joensuu H; Klemi PJ; Korkeila E
Am J Clin Pathol; 1988 Dec; 90(6):670-3. PubMed ID: 3195496
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of DNA ploidy in large cleaved cell lymphomas.
Aine R; Lehtinen T; Lehtinen M; Blanco G; Apaja-Sarkkinen M; Leinikki P; Alavaikko M
Hematol Oncol; 1990; 8(6):339-46. PubMed ID: 2286357
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of DNA flow cytometry combined with fine needle aspiration biopsy in lymphomas.
Joensuu H; Klemi PJ; Eerola E
J Pathol; 1988 Mar; 154(3):237-45. PubMed ID: 3351670
[TBL] [Abstract][Full Text] [Related]
30. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
Smaaland R; Lote K; Sothern RB; Laerum OD
Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
[TBL] [Abstract][Full Text] [Related]
31. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA
Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
[TBL] [Abstract][Full Text] [Related]
34. [Flowcytometry DNA analysis of oral and maxillofacial non-Hodgkin's lymphoma].
Ma L; He Z; Wu L; Cai Y; Huang H; Lei S
Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Jun; 20(3):193-6. PubMed ID: 12600064
[TBL] [Abstract][Full Text] [Related]
35. Pathological variables determining the prognosis of non-Hodgkin's lymphomas.
Kelly SA; Harkin PJ; Jack AS
Histopathology; 1992 Mar; 20(3):229-36. PubMed ID: 1563709
[TBL] [Abstract][Full Text] [Related]
36. DNA content and prognosis of non-Hodgkin's lymphoma.
Morgan DR; Williamson JM; Quirke P; Clayden AD; Smith ME; O'Brien CJ; Allison DL; Child JA; Bird CC
Br J Cancer; 1986 Oct; 54(4):643-9. PubMed ID: 3778806
[TBL] [Abstract][Full Text] [Related]
37. DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.
Erdkamp FL; Breed WP; Schouten HC; Janssen WC; Hoffmann JJ; Wijnen JT; Blijham GH
Ann Oncol; 1993 Jan; 4(1):75-80. PubMed ID: 8435368
[TBL] [Abstract][Full Text] [Related]
38. [Survival of patients and DNA-ploidy of cells in non-Hodgkin's lymphoma of low-grade malignancy].
Urasiński I; Urasiński T; Krygier-Stojałowska A
Acta Haematol Pol; 1994; 25(4):355-61. PubMed ID: 7847037
[TBL] [Abstract][Full Text] [Related]
39. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.
Nuutinen J; Leskinen S; Lindholm P; Söderström KO; Någren K; Huhtala S; Minn H
Eur J Nucl Med; 1998 Jul; 25(7):729-35. PubMed ID: 9662595
[TBL] [Abstract][Full Text] [Related]
40. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
Klemi PJ; Alanen K; Jalkanen S; Joensuu H
Br J Cancer; 1992 Oct; 66(4):739-43. PubMed ID: 1358164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
